Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning

BACKGROUND: Stroke is the second leading cause of disease-related death and the third leading cause of disability worldwide. However, how to accurately warn of stroke onset remains extremely challenging. Recently, phenylacetyl glutamine (PAGln) has been implicated in the onset of stroke, but evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Li, Fu, Guoping, Liu, Rongrong, Zhou, Feng, Dong, Shiye, Zhou, Yang, Lou, Jingwei, Wang, Xinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933389/
https://www.ncbi.nlm.nih.gov/pubmed/36797695
http://dx.doi.org/10.1186/s12883-023-03118-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933389/
https://www.ncbi.nlm.nih.gov/pubmed/36797695
http://dx.doi.org/10.1186/s12883-023-03118-5

Ejemplares similares